首页> 外文期刊>Clinical and experimental allergy : >Predominance of the major allergen (Alt aI) inAlternariasensitized patients
【24h】

Predominance of the major allergen (Alt aI) inAlternariasensitized patients

机译:Predominance of the major allergen (Alt aI) inAlternariasensitized patients

获取原文
           

摘要

SummaryThirty‐nine patients sensitized toAlternariawere evaluated using titrated skin‐prick test (SPT), histamine release studies (HR), inhibition of RAST and immunoblotting studies. To determine the relevance of the major allergen,Alt aI, specific rabbit antibodies againstAlt aI andAlt aB were used. The antibodies were preincubated at different concentrations: (i) with theAlternariaallergen dose required for maximum response in the HR assay (10 BU/ml) and (ii) with theAlternariaantigen coupled to RAST paper discs (1000 BU/disc). Dose dependent inhibition of histamine release (n= 30, x̄= 80± 4, IC30 = 0.69 μg/ml) and of RAST (n= 7, IC30 = 4.4 μg/ml) was found in all patients sensitized toAlternariaas indicated by allergen induced HR. The greater the response toAlternariain HR, the higher the antibody concentrations necessary for inhibition (P<0.05). Immunoblot experiments (n=25) using SDS‐PAGE showed in all cases IgE‐ and IgG binding at approximately 28 kD, which is the size reported for the major allergen.All aI. In two cases, slight IgE binding at 45 and 66 kD was also found, while in two other patients, only IgE binding at 66 kD was seen. Our findings emphasize the major importance ofAlt aI in patients sensitized t

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号